Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15Ink4B

被引：183

作者：

Feng, XH ^{[1
]}

Liang, YY

Liang, M

Zhai, WG

Lin, X

机构：

[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

[3] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA

来源：

MOLECULAR CELL | 2002年 / 9卷 / 01期

关键词：

D O I：

10.1016/S1097-2765(01)00430-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The c-Myc oncogene has been implicated in the genesis of diverse human tumors. Ectopic expression of the c-Myc gene in cultured epithelial cells causes resistance to the antiproliferative effects of TGF-beta. However, little is known about the precise mechanisms of c-Myc-mediated TGF-beta resistance. In this study, we reveal that c-Myc physically interacts with Smad2 and Smad3, two specific signal transducers involved in TGF-beta signaling. Through its direct interaction with Smads, c-Myc binds to the Sp1-Smad complex on the promoter of the p15(Ink4B) gene, thereby inhibiting the TGF-beta-induced transcriptional activity of Sp1 and Smad/Sp1-dependent transcription of the p15(Ink4B) gene. These results suggest that oncogenic c-Myc promotes cell growth and cancer development partly by inhibiting the growth inhibitory functions of Smads.

引用

页码：133 / 143

页数：11

共 50 条

[11] Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides [J].

Coulis, CM ;

Lee, C ;

Nardone, V ;

Prokipcak, RD .

MOLECULAR PHARMACOLOGY, 2000, 57 (03) :485-494

[12]

Dang CV, 1999, MOL CELL BIOL, V19, P1

[13] TRANSFORMING GROWTH-FACTOR-BETA INDUCES THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 THROUGH A P53-INDEPENDENT MECHANISM [J].

DATTO, MB ;

LI, Y ;

PANUS, JF ;

HOWE, DJ ;

XIONG, Y ;

WANG, XF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5545-5549

[14] Smads:: Transcriptional activators of TGF-β responses [J].

Derynck, R ;

Zhang, Y ;

Feng, XH .

CELL, 1998, 95 (06) :737-740

[15]

DERYNCK R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105

[16]

Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504

[17] MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].

Eppert, K ;

Scherer, SW ;

Ozcelik, H ;

Pirone, R ;

Hoodless, P ;

Kim, H ;

Tsui, LC ;

Bapat, B ;

Gallinger, S ;

Andrulis, IL ;

Thomsen, GH ;

Wrana, JL ;

Attisano, L .

CELL, 1996, 86 (04) :543-552

[18] Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β [J].

Feng, XH ;

Lin, X ;

Derynck, R .

EMBO JOURNAL, 2000, 19 (19) :5178-5193

[19] The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation [J].

Feng, XH ;

Zhang, Y ;

Wu, RY ;

Derynck, R .

GENES & DEVELOPMENT, 1998, 12 (14) :2153-2163

[20] TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA)-INDUCED DOWN-REGULATION OF CYCLIN-A EXPRESSION REQUIRES A FUNCTIONAL TGF-BETA RECEPTOR COMPLEX - CHARACTERIZATION OF CHIMERIC AND TRUNCATED TYPE-I AND TYPE-II RECEPTORS [J].

FENG, XH ;

FILVAROFF, EH ;

DERYNCK, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24237-24245

← 1 2 3 4 5 →